Brief: InVivo Therapeutics reports qtrly adj. loss $0.19/shr
March 4 (Reuters) - InVivo Therapeutics Holdings Corp NVIV.O : * Reports 2015 year end financial results and business update * Qtrly GAAP net loss per diluted share $0.17 * Says qtrly adjusted net loss per diluted share $0.19 * Source text for Eikon urn:newsml:reuters.com:*:nBwcfZKtGa * Further company coverage NVIV.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR